There was a numerical trend toward a smaller change in monthly migraine headache days after treatment discontinuation as the treatment duration increased.
← all excerpts
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
1
—
—